Literature DB >> 6300686

Detection of HSV-1 genome in central nervous system of latently infected mice.

D L Rock, N W Fraser.   

Abstract

Herpes simplex virus type 1 (HSV-1) can establish latent infections in peripheral nerve ganglia and the central nervous system (CNS) of experimentally infected mice. Latent infections of peripheral nervous tissue are characterized by the ability to recover infectious virus from explant cultures of most of the latently infected ganglia. In contrast, infectious virus is infrequently recovered from the CNS of latently infected mice following explant culture, although viral DNA can be detected in CNS tissue. The presence of incomplete or defective viral genomes during the latent CNS infections has been proposed to explain this difference between the two latent infections. To characterize the completeness and the physical state of the latent viral genome, we used Southern blot hybridization to analyse the viral DNA from latently infected mouse ganglia and brains. Our results, reported here, indicate that most, if not all, of the HSV-1 genome is present in latently infected CNS tissue and that the latent viral genome exists in a form other than linear, unit length DNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300686     DOI: 10.1038/302523a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  113 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Replication of the herpes simplex virus genome: does it really go around in circles?

Authors:  Rozanne M Sandri-Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

3.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Localization of herpes simplex virus type 1 DNA in latently infected BALB/c mice neurons using in situ polymerase chain reaction.

Authors:  Behzad Khansarinejad; Hoorieh Soleimanjahi; Amir Ghaemi; Taki Tiraihi; Shahram Pour Beiranvand
Journal:  Iran Biomed J       Date:  2010-07

5.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.

Authors:  D L Rock; A B Nesburn; H Ghiasi; J Ong; T L Lewis; J R Lokensgard; S L Wechsler
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Detection of herpes simplex virus type 1 transcripts during latent infection in mice.

Authors:  J G Spivack; N W Fraser
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency.

Authors:  M U Fareed; J G Spivack
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.